Stem cell-based test predicts leukemia patients’ response to therapy to tailor treatment – Medical Xpress
Medical Xpress |
Stem cell-based test predicts leukemia patients' response to therapy to tailor treatment
Medical Xpress The new biomarker is named the LSC17 score as it comes from the leukemia stem cells that drive disease and relapse. These dormant stem cells have properties that allow them to resist standard chemotherapy, which is designed to defeat rapidly dividing … Signature of 17 Genes Could Predict Prognosis in AML Patients |
